naringenin and gw9662
naringenin has been researched along with gw9662 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Balaguer, P; Chung, RT; Cohen, PY; Goldwasser, J; Kitsberg, D; Lin, W; Nahmias, Y; Polyak, SJ; Yarmush, ML | 1 |
Other Studies
1 other study(ies) available for naringenin and gw9662
| Article | Year |
|---|---|
Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism.
Topics: Anilides; Anti-Ulcer Agents; Apolipoprotein B-100; Brefeldin A; Carrier Proteins; Cell Line, Tumor; Citrus paradisi; Flavanones; Hepacivirus; Hepatocytes; Humans; Lipoproteins, VLDL; PPAR gamma; RNA, Viral; Viral Core Proteins; Virus Assembly | 2011 |